MA
VIVE

MYDA Advisors’s VIVEVE MED INC VIVE Stock Holding History

MYDA Advisors’s Portfolio VIVE Stock Details VIVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-132
Closed -$138K – 146
2018
Q4 		$138K Buy
132
+79
+149% +$190K 0.24% 54
2018
Q3 		$142K Buy
+53
New +$150K 0.08% 120
2018
Q2 		– Sell
-74
Closed -$271K – 204
2018
Q1 		$271K Sell
74
-11
-13% -$47.8K 0.18% 90
2017
Q4 		$422K Buy
+85
New +$442K 0.19% 99

Other funds holding VIVE

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

MYDA Advisors's VIVE Position: Q1 2019 in Review

MYDA Advisors sold out of VIVEVE MED INC (VIVE) in Q1 2019, closing a stake of 132 shares — an estimated $138K sold.

MYDA Advisors first reported a position in VIVE in Q4 2017 and held it in 4 quarters. The position peaked at $422K in Q4 2017. 30 funds tracked by Wall St. Rank hold VIVE as of Q1 2019.

  • MYDA Advisors reported no remaining VIVEVE MED INC position as of Q1 2019 after selling out during the quarter.
  • MYDA Advisors sold 132 VIVEVE MED INC shares in Q1 2019, an estimated $138K.
  • MYDA Advisors first reported a position in VIVEVE MED INC in Q4 2017 and held it in 4 quarters.
  • MYDA Advisors's VIVEVE MED INC position peaked at $422K in Q4 2017.
  • 30 funds tracked by Wall St. Rank held VIVEVE MED INC as of Q1 2019.

Based on MYDA Advisors's 13F filing for Q1 2019, filed 13 May 2019.